Tumor Analysis Platform Predicts Personalized Drug Combos for Non-Hodgkin Lymphoma Patients
Among NHL patients who received off-label therapy with combinations generated by the platform, nearly half achieved partial or complete responses.
National University Hospital Singapore General United States United Kingdom National University Of Singapore Edward Chow
Source: precisiononcologynews.com